Pacific Biosciences of California Inc (NASDAQ:PACB)
| 4.46 BATS BZX Real-Time Price As of 12:31pm ET |  +0.025 / +0.56%Today’s Change | 3.85 Today|||52-Week Range 35.58 | -78.23% Year-to-Date |
Institutional investors purchased a net $14.6 million shares of PACB during the quarter ended June 2019 and now own 92.95% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Individual stakeholders | 6.70% |
| Mutual fund holders | 54.15% |
| Other institutional | 38.80% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2022 | JACKSON SQUARE PARTNERS LLC Bought 8.0 Million shares of Pacific Biosciences of Ca... |
| 3/31/2022 | BELLEVUE ASSET MANAGEMENT AG Bought 3.3 Million shares of Pacific Biosciences of Ca... |
| 3/31/2022 | TWO SIGMA INVESTMENTS LP Bought 2.7 Million shares of Pacific Biosciences of Ca... |
Top 10 Owners of Pacific Biosciences of California Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 12.15% | 27,259,521 | 153,471,103 | +876,418 | +3.32% |
| Jackson Square Partners LLC | 10.05% | 22,542,589 | 126,914,776 | +8,039,420 | +55.43% |
| The Vanguard Group, Inc. | 8.70% | 19,518,268 | 109,887,849 | +100,971 | +0.52% |
| Nikko Asset Management Americas, ... | 6.25% | 14,021,205 | 78,939,384 | +2,106,180 | +17.68% |
| BlackRock Fund Advisors | 6.16% | 13,822,609 | 77,821,289 | +22,487 | +0.16% |
| Capital Research & Management Co.... | 5.70% | 12,781,855 | 71,961,844 | +675,537 | +5.58% |
| Casdin Capital LLC | 3.56% | 7,990,652 | 44,987,371 | 0 | 0.00% |
| T. Rowe Price Associates, Inc. (I... | 2.72% | 6,104,093 | 34,366,044 | +270,289 | +4.63% |
| Baker Bros. Advisors LP | 2.43% | 5,444,963 | 30,655,142 | 0 | 0.00% |
| Bellevue Asset Management AG | 2.18% | 4,881,752 | 27,484,264 | +3,328,729 | +214.34% |
Top 10 Mutual Funds Holding Pacific Biosciences of California Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Innovation ETF | 6.13% | 13,746,726 | 77,394,067 | +45,214 | +0.33% |
| ARK Genomic Revolution ETF | 5.42% | 12,169,210 | 68,512,652 | 0 | 0.00% |
| American Funds Small Cap World Fu... | 4.97% | 11,146,935 | 62,757,244 | +680,169 | +6.50% |
| Vanguard Total Stock Market Index... | 2.78% | 6,236,803 | 35,113,201 | +135,731 | +2.22% |
| Nikko AM Global Umbrella Fund - A... | 2.71% | 6,090,024 | 34,286,835 | +2,023,148 | +49.75% |
| Jackson Square SMID Cap Growth Fu... | 2.68% | 6,020,490 | 33,895,359 | -145,327 | -2.36% |
| Vanguard Small Cap Index Fund | 2.34% | 5,249,537 | 29,554,893 | -14,085 | -0.27% |
| Nikko AM Global Umbrella Fund - A... | 2.15% | 4,834,195 | 27,216,518 | +1,958,431 | +68.10% |
| iShares Russell 2000 ETF | 1.96% | 4,389,539 | 24,713,105 | +14,117 | +0.32% |
| American Funds Growth Fund of Ame... | 1.72% | 3,850,690 | 21,679,385 | 0 | 0.00% |